Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,690
  • Shares Outstanding, K 23,580
  • Annual Sales, $ 28,780 K
  • Annual Income, $ -25,680 K
  • 36-Month Beta 2.94
  • Price/Sales 4.51
  • Price/Cash Flow N/A
  • Price/Book 2.67

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.01 +5.39%
on 06/22/18
6.50 -18.77%
on 06/05/18
-0.51 (-8.81%)
since 05/25/18
3-Month
5.01 +5.39%
on 06/22/18
8.42 -37.29%
on 05/15/18
-0.82 (-13.44%)
since 03/23/18
52-Week
2.07 +155.07%
on 12/18/17
8.42 -37.29%
on 05/15/18
+0.84 (+18.92%)
since 06/23/17

Most Recent Stories

More News
Pfenex Set to Join Russell 2000(R) Index

Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology(R) to improve protein therapies for unmet patient...

PFNX : 5.27 (-4.18%)
Pfenex to Present at the JMP Securities 2018 Life Science Conference

Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the JMP Securities 2018 Life Science Conference in New York City.

PFNX : 5.27 (-4.18%)
Pfenex and Alvogen Enter into U.S. Agreement for Commercialization of PF708, a Therapeutic Equivalent Candidate to Forteo(R)

Pfenex (NYSE American:PFNX) and Alvogen today announced entering into an agreement granting Alvogen exclusive rights to commercialize Pfenex's lead drug candidate, PF708, a teriparatide therapeutic equivalent...

PFNX : 5.27 (-4.18%)
LLY : 85.64 (-0.33%)
Pfenex to Present at the Jefferies 2018 Global Healthcare Conference

Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the Jefferies 2018 Global Healthcare Conference in New York City.

PFNX : 5.27 (-4.18%)
Pfenex Announces Pricing of Offering of 6,800,000 Shares of Common Stock

Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology to improve protein therapies for unmet patient...

PFNX : 5.27 (-4.18%)
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for unmet patient...

PFNX : 5.27 (-4.18%)
Pfenex Reports First Quarter 2018 Results and Provides Business Update

Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for unmet patient...

PFNX : 5.27 (-4.18%)
What Downbeat 2018? These 5 Top Stocks Are Up More Than 100%

These five stocks gained more than 100% defying the market sluggishness this year.

ENVA : 35.05 (-3.97%)
PFNX : 5.27 (-4.18%)
ECYT : 13.39 (-2.90%)
WTI : 6.61 (-6.77%)
HEAR : 19.87 (-7.92%)
Pfenex Inc Up 78.3% Since SmarTrend Uptrend Call (PFNX)

SmarTrend identified an Uptrend for Pfenex Inc (AMEX:PFNX) on December 19th, 2017 at $2.95. In approximately 5 months, Pfenex Inc has returned 78.27% as of today's recent price of $5.25.

PFNX : 5.27 (-4.18%)
Pfenex to Report First Quarter 2018 Results and Provide Business Update on Thursday, May 10th

Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, May 10, 2018, after the market close. Pfenex management will host a corresponding...

PFNX : 5.27 (-4.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade PFNX with:

Business Summary

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform...

See More

Key Turning Points

2nd Resistance Point 5.89
1st Resistance Point 5.70
Last Price 5.27
1st Support Level 5.16
2nd Support Level 4.81

See More

52-Week High 8.42
Fibonacci 61.8% 5.99
Last Price 5.27
Fibonacci 50% 5.24
Fibonacci 38.2% 4.50
52-Week Low 2.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar